# Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

> **NCT01666704** · PHASE2 · WITHDRAWN · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Atherosclerotic Cardiovascular Disease

## Interventions

- **DRUG:** BMS-823778
- **DRUG:** BMS-823778
- **DRUG:** Placebo matching with BMS-823778

## Key facts

- **NCT ID:** NCT01666704
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2015-10
- **Final completion:** 2016-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666704, "Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01666704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*